Schäfer-Graf, U.M. ; Laubner, K. ; Hummel, S. ; Gembruch, U. ; Groten, T. ; Kainer, F. ; Grieshop, M. ; Bancher-Todesca, D. ; Cervar-Zivakovic, M. ; Hösli, I. ; Kaltheuner, M. ; Gellner, R. ; Kautzky-Willer, A. ; Bührer, C. ; Patchev, V. ; Nothacker, M.
Erratum: Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge:: Praxisempfehlung - Kurzfassung der S3-Leitlinie (AWMF-Registernummer: 057-008) (Diabetologie und Stoffwechsel (2018) 13:Suppl 2 (S174-S184) DOI: 10.1055/a-0598-3468).Smith, L.B. ; Liu, X. ; Johnson, S.B. ; Tamura, R. ; Elding Larsson, H. ; Ahmed, S. ; Veijola, R. ; Haller, M.J. ; Akolkar, B. ; Hagopian, W.A. ; Rewers, M.J. ; Krischer, J. ; Steck, A.K. ; TEDDY Study Group (Ziegler, A.-G. ; Beyerlein, A. ; Hummel, M. ; Hummel, S. ; Janz, N. ; Knopff, A. ; Peplow, C. ; Roth, R. ; Scholz, M. ; Stock, J. ; Strauss, E. ; Warncke, K. ; Wendel, L. ; Winkler, C.)
Family adjustment to diabetes diagnosis in children: Can participation in a study on type 1 diabetes genetic risk be helpful?Stanfill, B.A. ; Nakayasu, E.S. ; Bramer, L.M. ; Thompson, A.M. ; Ansong, C.K. ; Clauss, T.R. ; Gritsenko, M.A. ; Monroe, M.E. ; Moore, R.J. ; Orton, D.J. ; Piehowski, P.D. ; Schepmoes, A.A. ; Smith, R.D. ; Webb-Robertson, B.M. ; Metz, T.O. ; TEDDY Study Group (Ziegler, A.-G. ; Beyerlein, A. ; Hummel, M. ; Hummel, S. ; Knopff, A. ; Roth, R. ; Scholz, M. ; Stock, J. ; Warncke, K. ; Wendel, L. ; Winkler, C.)
Quality control analysis in real-time (QC-ART): A tool for real-time quality control assessment of mass spectrometry-based proteomics data.Schäfer-Graf, U.M. ; Gembruch, U. ; Kainer, F. ; Groten, T. ; Hummel, S. ; Hösli, I. ; Grieshop, M. ; Kaltheuner, M. ; Bührer, C. ; Kautzky-Willer, A. ; Laubner, K. ; Bancher-Todesca, D.
Gestational Diabetes Mellitus (GDM) - Diagnosis, Treatment and Follow-Up. Guideline of the DDG and DGGG (S3 Level, AWMF Registry Number 057/008, February 2018).Wolf, S. ; Hoffmann, V. ; Habicht, A. ; Kauke, T. ; Bucher, J.B. ; Schoenberg, M.H. ; Werner, J. ; Guba, M. ; Andrassy, J.
Effects of MTOR-IS on malignancy and survival following renal transplantation: A systematic review and meta-analysis of randomized trials with a minimum follow-up of 24 months.Salami, F. ; Lee, H. ; Freyhult, E. ; Larsson, H.E. ; Lernmark, A. ; Törn, C. ; TEDDY Study Group (Ziegler, A.-G. ; Beyerlein, A. ; Gavrisan, A. ; Gezginci, C. ; Hummel, M. ; Hummel, S. ; Knopff, A. ; Koletzko, S. ; Stock, J. ; Scholz, M. ; Roth, R. ; Warncke, K. ; Wendel, L. ; Winkler, C.)
Reduction in white blood cell, neutrophil, and red blood cell counts related to sex, HLA, and islet autoantibodies in Swedish TEDDY children at increased risk for type 1 diabetes.Schaefer-Graf, U. ; Laubner, K. ; Hummel, S. ; Gembruch, U. ; Groten, T. ; Kainer, F. ; Grieshop, M. ; Bancher-Todesca, D. ; Cervar-Zivakovic, M. ; Hoesli, I. ; Kaltheuner, M. ; Gellner, R. ; Kautzky-Willer, A. ; Buehrer, C. ; Patchev, V. ; Nothacker, M.
Gestational diabetes mellitus (GDM), diagnosis, therapy and follow-up.Vatanen, T. ; Franzosa, E.A. ; Schwager, R. ; Tripathi, S. ; Arthur, T.D. ; Vehik, K. ; Lernmark, Å. ; Hagopian, W.A. ; Rewers, M.J. ; She, J.X. ; Toppari, J. ; Ziegler, A.-G. ; Akolkar, B. ; Krischer, J.P. ; Stewart, C.J. ; Ajami, N.J. ; Petrosino, J.F. ; Gevers, D. ; Lähdesmäki, H. ; Vlamakis, H. ; Huttenhower, C. ; Xavier, R.J.
The human gut microbiome in early-onset type 1 diabetes from the TEDDY study.Stewart, C.J. ; Ajami, N.J. ; O’Brien, J.L. ; Hutchinson, D.S. ; Smith, D.P. ; Wong, M.C. ; Ross, M.C. ; Lloyd, R.E. ; Doddapaneni, H.V. ; Metcalf, G.A. ; Muzny, D. ; Gibbs, R.A. ; Vatanen, T. ; Huttenhower, C. ; Xavier, R.J. ; Rewers, M. ; Hagopian, W. ; Toppari, J. ; Ziegler, A.-G. ; She, J.X. ; Akolkar, B. ; Lernmark, A. ; Hyoty, H. ; Vehik, K. ; Krischer, J.P. ; Petrosino, J.F.
Temporal development of the gut microbiome in early childhood from the TEDDY study.Rewers, M. ; Hyöty, H. ; Lernmark, Å. ; Hagopian, W. ; She, J.X. ; Schatz, D. ; Ziegler, A.-G. ; Toppari, J. ; Akolkar, B. ; Krischer, J.
The Environmental Determinants of Diabetes in the Young (TEDDY) Study: 2018 Update.Pfirrmann, M. ; Baccarani, M. ; Saussele, S. ; Faber, E. ; Bogdanovic, A. ; Clark, R. ; Hehlmann, R. ; Hoffmann, V.
The EUTOS long-term survival (ELTS) score is superior to the Sokal score for prognosis of probabilities of dying of chronicphase chronic myeloid leukaemia.Köhler, M. ; Umlauf, N. ; Greven, S.
Nonlinear association structures in flexible Bayesian additive joint models.Rodriguez-Calvo, T.
Enterovirus infection and type 1 diabetes: Unraveling the crime scene.Endesfelder, D. ; zu Castell, W. ; Bonifacio, E. ; Rewers, M. ; Hagopian, W.A. ; She, J.X. ; Lernmark, A. ; Toppari, J. ; Vehik, K. ; Williams, A.J.K. ; Yu, L. ; Akolkar, B. ; Krischer, J.P. ; Ziegler, A.-G. ; Achenbach, P.
Time-resolved autoantibody profiling facilitates stratification of preclinical type 1 diabetes in children.Beyerlein, A. ; Bonifacio, E. ; Vehik, K. ; Hippich, M. ; Winkler, C. ; Frohnert, B.I. ; Steck, A.K. ; Hagopian, W.A. ; Krischer, J.P. ; Lernmark, Å. ; Rewers, M.J. ; She, J.X. ; Toppari, J. ; Akolkar, B. ; Rich, S.S. ; Ziegler, A.-G.
Progression from islet autoimmunity to clinical type 1 diabetes is influenced by genetic factors: Results from the prospective TEDDY study.Rodriguez-Calvo, T. ; Richardson, S.J. ; Pugliese, A.
Pancreas pathology during the natural history of type 1 diabetes.Sioofy-Khojine, A. ; Oikarinen, S. ; Honkanen, H. ; Huhtala, H. ; Lehtonen, J.P. ; Briese, T. ; Hyoty, H. ; TEDDY Study Group (Ziegler, A.-G. ; Beyerlein, A. ; Hummel, M. ; Hummel, S. ; Knopff, A. ; Scholz, M. ; Stock, J. ; Warncke, K. ; Wendel, L. ; Winkler, C.)
Molecular epidemiology of enteroviruses in young children at increased risk of type 1 diabetes.Pitchika, A. ; Vehik, K. ; Hummel, S. ; Norris, J.M. ; Uusitalo, U.M. ; Yang, J. ; Virtanen, S.M. ; Koletzko, S. ; Aronsson, C.A. ; Ziegler, A.-G. ; Beyerlein, A.
Associations of maternal diabetes during pregnancy with overweight in offspring: Results from the prospective TEDDY study.Kick, K. ; Hoffmann, V. ; Lange, K. ; Lang, M. ; Laub, O. ; Bechtold-Dalla Pozza, S. ; Böcker, D. ; Braig, S. ; Dietz, B. ; Dunstheimer, D. ; Eber, S. ; Ermer, U. ; Gavazzeni, A. ; Gerstl, E.M. ; Götz, M. ; Huhn, F. ; Kuhnle-Krahl, U. ; Landendörfer, W. ; Leipold, G. ; Leppik, K.-H. ; Müller, H. ; Müller, I. ; Nellen-Hellmuth, N. ; Ockert, C. ; Renner, C. ; Sindichakis, M. ; Tretter, S. ; Warncke, K. ; Winkler, C. ; Zeller, S. ; Achenbach, P. ; Ziegler, A.-G.
Feasibility and organization of a population-based screening for pre-symptomatic type 1 diabetes in children – Evaluation of the Fr1da study.Mathieu, C. ; Lahesmaa, R. ; Bonifacio, E. ; Achenbach, P. ; Tree, T.
Immunological biomarkers for the development and progression of type 1 diabetes.Rodriguez-Calvo, T.
Enteroviral infections as a trigger for type 1 diabetes.Holthaus, L. ; Lamp, D. ; Gavrisan, A. ; Sharma, V. ; Ziegler, A.-G. ; Jastroch, M. ; Bonifacio, E.
CD4+ T cell activation, function, and metabolism are inhibited by low concentrations of DMSO.Zissler, U.M. ; Ulrich, M. ; Jakwerth, C.A. ; Bahmer, T. ; Weckmann, M. ; Schmidt-Weber, C.B. ; Chaker, A.M.
Potential of upper airway mediators as biomarkers for asthmatic lung.Heinrich, M. ; Maison, N. ; Achenbach, P. ; Assfalg, R. ; Braig, S. ; Böcker, D. ; Dunstheimer, D. ; Ermer, U. ; Gavazzeni, A. ; Gerstl, E.M. ; Hummel, S. ; Kick, K. ; Müller, H. ; Nellen-Hellmuth, N. ; Ockert, C. ; Sindichakis, M. ; Tretter, S. ; Warncke, K. ; Ziegler, A.-G. ; Beyerlein, A.
Fasting hypoglycemia is associated with disease progression in presymptomatic early stage type 1 diabetes.Kick, K. ; Assfalg, R. ; Aydin, S. ; Bechtold-Dalla Pozza, S. ; Böcker, D. ; Braig, S. ; Bunk, M. ; Dunstheimer, D. ; Durmashkina, A. ; Ermer, U. ; Gavazzeni, A. ; Gerstl, E.M. ; Heinrich, M. ; Herbst, M. ; Kriesen, Y. ; Kuhnle-Krahl, U. ; Müller, H. ; Nellen-Hellmuth, N. ; Ockert, C. ; Ramminger, C. ; Sindichakis, M. ; Tretter, S. ; Warncke, K. ; Achenbach, P. ; Ziegler, A.-G. ; Hoffmann, V.
Recruiting young pre-symptomatic children for a clinical trial in type 1 diabetes: Insights from the Fr1da insulin intervention study.Winkler, C. ; Ziegler, A.-G.
Neue Studie zur Prävention von Typ-1-Diabetes.Hartmann, B. ; Bramlage, P. ; Lanzinger, S. ; Danne, T. ; Hummel, M. ; Kaltheuner, M. ; Raddatz, D. ; Rathmann, W. ; Reuter, H.M. ; Seufert, J. ; Holl, R.W.
Regional differences in type 2 diabetes treatment and outcomes in Germany-An analysis of the German DPV and DIVE registries.Couper, J.J. ; Haller, M.J. ; Greenbaum, C.J. ; Ziegler, A.-G. ; Wherrett, D.K. ; Knip, M. ; Craig, M.E.
ISPAD Clinical Practice Consensus Guidelines 2018: Stages of type 1 diabetes in children and adolescents.Pitchika, A. ; Jolink, M. ; Winkler, C. ; Hummel, S. ; Hummel, N. ; Krumsiek, J. ; Kastenmüller, G. ; Raab, J. ; Kordonouri, O. ; Ziegler, A.-G. ; Beyerlein, A.
Associations of maternal type 1 diabetes with childhood adiposity and metabolic health in the offspring: A prospective cohort study.Müller, D. ; Telieps, T. ; Eugster, A. ; Weinzierl, C. ; Jolink, M. ; Ziegler, A.-G. ; Bonifacio, E.
Novel minor HLA DR associated antigens in type 1 diabetes.Tavira, B. ; Barcenilla, H. ; Wahlberg, J. ; Achenbach, P. ; Ludvigsson, J. ; Casas, R.
Intralymphatic glutamic acid decarboxylase (GAD)-alum administration induced Th2-like specific immunomodulation in responder patients: a pilot clinical trial in type 1 diabetes.Warncke, K. ; Flores, D. ; Heinrich, M. ; Aydin, S.E. ; Burdach, S.
Behandlung des Typ-1-Diabetes im Frühstadium: eine Kasuistik.Achenbach, P.
Früherkennung und präventive Behandlung des Typ-1-Diabetes.Beyerlein, A. ; Jolink, M.
Evaluation of the Fr1da screening: From an epidemiological perspective.Ziegler, A.-G. ; Ohli, J. ; Hoefs, T. ; Aydin, S.E. ; Falk, C. ; Gross, J.
Früherkennung und Primärprävention des Typ-1-Diabetes: „Global Platform for the Prevention of Autoimmune Diabetes“ (GPPAD).Achenbach, P.
Typ-1-Diabetes im asymptomatischen Frühstadium: Orales Insulin zur präventiven Behandlung.Winkler, C. ; Kick, K. ; Haupt, F. ; Assfalg, R.
Früherkennung des Typ-1-Diabetes in der Fr1da-Studie: Diagnosestellung im asymptomatischen Stadium.Achenbach, P. ; Hawa, M.I. ; Krause, S. ; Lampasona, V. ; Jerram, S.T. ; Williams, A.J.K. ; Bonifacio, E. ; Ziegler, A.-G. ; Leslie, R.D.
Autoantibodies to N-terminally truncated GAD improve clinical phenotyping of individuals with adult-onset diabetes: Action LADA 12.Hippich, M. ; Oleynik, A. ; Jain, K. ; Winkler, C. ; Ferreira, R.C. ; Bonifacio, E. ; Ziegler, A.-G. ; Briese, T.
Searching peripheral blood mononuclear cells of children with viral respiratory tract infections preceding islet autoimmunity for viruses by high-throughput sequencing.Riikonen, A. ; Hadley, D. ; Uusitalo, U. ; Miller, N. ; Koletzko, S. ; Yang, J. ; Andrén Aronsson, C. ; Hummel, S. ; Norris, J.M. ; Virtanen, S.M.
Milk feeding and first complementary foods during the first year of life in the TEDDY study.Albers, L. ; Sobotzki, C. ; Kuß, O. ; Ajslev, T. ; Batista, R.F. ; Bettiol, H. ; Brabin, B. ; Buka, S.L. ; Cardoso, V.C. ; Clifton, V.L. ; Devereux, G. ; Gilman, S.E. ; Grzeskowiak, L.E. ; Heinrich, J. ; Hummel, S. ; Jacobsen, G.W. ; Jones, G. ; Koshy, G. ; Morgen, C.S. ; Oken, E. ; Paus, T. ; Pausova, Z. ; Rifas-Shiman, S.L. ; Sharma, A.J. ; da Silva, A.A. ; Sørensen, T.I. ; Thiering, E. ; Turner, S.T. ; Vik, T. ; von Kries, R.
Maternal smoking during pregnancy and offspring overweight: Is there a dose-response relationship? An individual patient data meta-analysis.Kick, K. ; Ziegler, A.-G.
Immune preventive approaches for type-1-diabetes.Wolf, S. ; Hoffmann, V. ; Habicht, A. ; Kauke, T. ; Bucher, J.B. ; Schoenberg, M.H. ; Werner, J. ; Guba, M. ; Andrassy, J.
Effects of mTOR-Is on malignancy and survival following renal transplantation: A systematic review and meta-analysis of randomized trials with a minimum follow-up of 24 months.Bonifacio, E. ; Beyerlein, A. ; Hippich, M. ; Winkler, C. ; Vehik, K. ; Weedon, M.N. ; Laimighofer, M. ; Hattersley, A.T. ; Krumsiek, J. ; Frohnert, B.I. ; Steck, A.K. ; Hagopian, W.A. ; Krischer, J.P. ; Lernmark, A. ; Rewers, M.J. ; She, J.X. ; Toppari, J. ; Akolkar, B. ; Oram, R.A. ; Rich, S.S. ; Ziegler, A.-G.
Genetic scores to stratify risk of developing multiple islet autoantibodies and type 1 diabetes: A prospective study in children.Beyerlein, A. ; Lack, N. ; von Kries, R.
No further improvement in pregnancy-related outcomes in the offspring of mothers with pre-gestational diabetes in Bavaria, Germany, between 2001 and 2016.Wyatt, R.C. ; Brigatti, C. ; Liberati, D. ; Grace, S.L. ; Gillard, B.T. ; Long, A.E. ; Marzinotto, I. ; Shoemark, D. ; Chandler, K.A. ; Achenbach, P. ; Gillespie, K.M. ; Piemonti, L. ; Lampasona, V. ; Williams, A.J.K.
The first 142 amino acids of glutamate decarboxylase do not contribute to epitopes recognized by autoantibodies associated with Type 1 diabetes.Long, A.E. ; Wilson, I.V. ; Becker, D.J. ; Libman, I.M. ; Arena, V.C. ; Wong, F.S. ; Steck, A.K. ; Rewers, M.J. ; Yu, L. ; Achenbach, P. ; Casas, R. ; Ludvigsson, J. ; Williams, A.J.K. ; Gillespie, K.M.
Characteristics of slow progression to diabetes in multiple islet autoantibody-positive individuals from five longitudinal cohorts: The SNAIL study.Hummel, S. ; Beyerlein, A. ; Pfirrmann, M. ; Hofelich, A. ; Much, D. ; Hivner, S. ; Bunk, M. ; Herbst, M. ; Peplow, C. ; Walter, M. ; Kohn, D. ; Hummel, N. ; Kratzsch, J. ; Hummel, M. ; Füchtenbusch, M. ; Hasford, J. ; Ziegler, A.-G.
Efficacy of vildagliptin for prevention of postpartum diabetes in women with a recent history of insulin-requiring gestational diabetes: A phase II, randomized, double-blind, placebo-controlled study.Mehdi, A.M. ; Hamilton-Williams, E.E. ; Cristino, A. ; Ziegler, A.-G. ; Bonifacio, E. ; Le Cao, K.A. ; Harris, M.H. ; Thomas, R.
A peripheral blood transcriptomic signature predicts autoantibody development in infants at risk of type 1 diabetes.Uusitalo, U. ; Lee, H.S. ; Aronsson, C.A. ; Vehik, K. ; Yang, J.A. ; TEDDY Study Group (Hummel, S. ; Ziegler, A.-G. ; Teddy Study Group) ; Silvis, K. ; Lernmark, A. ; Rewers, M. ; Hagopian, W. ; She, J.X. ; Simell, O. ; Toppari, J. ; Akolkar, B. ; Krischer, J. ; Virtanen, S.M. ; Norris, J.M.
Early infant diet and islet autoimmunity in the TEDDY Study.Sharma, A. ; Liu, X. ; Hadley, D. ; Hagopian, W. ; Chen, W.M. ; Onengut-Gumuscu, S. ; Törn, C. ; Steck, A.K. ; Frohnert, B.I. ; Rewers, M. ; Ziegler, A.-G. ; Lernmark, A. ; Toppari, J. ; Krischer, J.P. ; Akolkar, B. ; Rich, S.S. ; She, J.X. ; TEDDY Study Group (The Teddy Study Group)
Identification of non-HLA genes associated with development of islet autoimmunity and type 1 diabetes in the prospective TEDDY cohort.Norris, J.M. ; Lee, H.S. ; Frederiksen, B. ; Erlund, I. ; Uusitalo, U. ; Yang, J.A. ; Lernmark, A. ; Simell, O. ; Toppari, J. ; Rewers, M. ; TEDDY Study Group (Ziegler, A.-G.) ; She, J.X. ; Onengut-Gumuscu, S. ; Chen, W.M. ; Rich, S.S. ; Sundvall, J. ; Akolkar, B. ; Krischer, J. ; Virtanen, S.M. ; Hagopian, W.
Plasma 25-hydroxyvitamin D concentration and risk of islet autoimmunity.Liberati, D. ; Wyatt, R.C. ; Brigatti, C. ; Marzinotto, I. ; Ferrari, M. ; Bazzigaluppi, E. ; Bosi, E. ; Gillard, B.T. ; Gillespie, K.M. ; Gorus, F. ; Weets, I. ; Balti, E. ; Piemonti, L. ; Achenbach, P. ; Williams, A.J.K. ; Lampasona, V.
A novel LIPS assay for insulin autoantibodies.Kindt, A. ; Fuerst, R.W. ; Knoop, J. ; Laimighofer, M. ; Telieps, T. ; Hippich, M. ; Woerheide, M.A. ; Wahl, S. ; Wilson, R. ; Sedlmeier, E.-M. ; Hommel, A. ; Todd, J.A. ; Krumsiek, J. ; Ziegler, A.-G. ; Bonifacio, E.
Allele-specific methylation of type 1 diabetes susceptibility genes.Heussinger, N. ; Della Marina, A. ; Beyerlein, A. ; Leiendecker, B. ; Hermann-Alves, S. ; Dalla Pozza, R. ; Klepper, J.
10 patients, 10 years - Long term follow-up of cardiovascular risk factors in Glut1 deficiency treated with ketogenic diet therapies: A prospective, multicenter case series.Lynch, K.F. ; Lee, H.S. ; Törn, C. ; Vehik, K. ; Krischer, J.P. ; Larsson, H.E. ; Haller, M.J. ; Hagopian, W.A. ; Rewers, M.J. ; She, J.X. ; Simell, O.G. ; Toppari, J. ; Ziegler, A.-G. ; Akolkar, B. ; Hyöty, H. ; Bonifacio, E. ; Lernmark, A.
Gestational respiratory infections interacting with offspring HLA and CTLA-4 modifies incident beta-cell autoantibodies.Bohn, B. ; Bramlage, P. ; Wagner, C. ; Kaltheuner, M. ; Welp, R. ; Sziegoleit, S. ; Zimmermann, A. ; Reuter, H.M. ; Hummel, M. ; Gloyer, J. ; Holl, R.W. ; Danne, T.
Welche Patienten aus der Routinebetreuung verwenden das neue Insulin-Analogon Glargin U300 im Vergleich zu Patienten mit Glargin U100? Eine multizentrische Analyse von 14.123 Patienten mit Insulin Glargin aus den Diabetesregistern DPV und DIVE.Frohnert, B.I. ; Laimighofer, M. ; Krumsiek, J. ; Theis, F.J. ; Winkler, C. ; Norris, J.M. ; Ziegler, A.-G. ; Rewers, M.J. ; Steck, A.K.
Prediction of type 1 diabetes using a genetic risk model in the Diabetes Autoimmunity Study in the Young.